Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 31 04:00PM ET
1.92
Dollar change
-0.10
Percentage change
-4.95
%
Index- P/E- EPS (ttm)-2.18 Insider Own19.30% Shs Outstand48.08M Perf Week0.52%
Market Cap92.81M Forward P/E- EPS next Y-1.50 Insider Trans0.00% Shs Float39.01M Perf Month-5.42%
Income-104.56M PEG- EPS next Q-0.41 Inst Own40.47% Short Float13.44% Perf Quarter20.75%
Sales0.00M P/S- EPS this Y34.41% Inst Trans-19.12% Short Ratio4.43 Perf Half Y-39.24%
Book/sh0.65 P/B2.96 EPS next Y11.61% ROA-84.23% Short Interest5.24M Perf Year30.61%
Cash/sh1.28 P/C1.51 EPS next 5Y- ROE-134.14% 52W Range1.14 - 4.02 Perf YTD-21.95%
Dividend Est.- P/FCF- EPS past 5Y-25.30% ROI-333.30% 52W High-52.24% Beta1.04
Dividend TTM- Quick Ratio3.81 Sales past 5Y-56.91% Gross Margin- 52W Low68.42% ATR (14)0.15
Dividend Ex-Date- Current Ratio3.81 EPS Y/Y TTM17.51% Oper. Margin0.00% RSI (14)49.15 Volatility6.50% 7.91%
Employees65 Debt/Eq0.05 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price8.67
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q41.69% Payout- Rel Volume0.50 Prev Close2.02
Sales Surprise- EPS Surprise1.81% Sales Q/Q- EarningsNov 07 AMC Avg Volume1.18M Price1.92
SMA20-3.59% SMA502.90% SMA200-10.26% Trades Volume587,731 Change-4.95%
Date Action Analyst Rating Change Price Target Change
Sep-15-22Initiated JMP Securities Mkt Outperform $17
May-05-22Downgrade Credit Suisse Outperform → Neutral $35 → $5
Mar-21-22Initiated H.C. Wainwright Buy $25
Oct-15-21Resumed BTIG Research Buy $68
Jun-28-21Initiated ROTH Capital Buy $75
May-05-21Resumed Credit Suisse Outperform $68
Apr-26-21Resumed Credit Suisse Outperform $68
Jan-11-21Initiated JP Morgan Overweight $45
Jan-11-21Initiated Jefferies Buy $51
Jan-11-21Initiated Credit Suisse Outperform $49
Today 08:00AM
Oct-20-24 04:06PM
Oct-09-24 05:57PM
Oct-04-24 09:05AM
Oct-01-24 08:00AM
07:30AM Loading…
Sep-23-24 07:30AM
Sep-16-24 08:00AM
Sep-09-24 08:00AM
Aug-28-24 08:00AM
Aug-08-24 04:05PM
Aug-01-24 08:00AM
Jul-31-24 01:11PM
Jul-25-24 05:39PM
Jul-24-24 12:54PM
Jul-23-24 08:00AM
08:00AM Loading…
Jun-27-24 08:00AM
May-29-24 08:00AM
May-23-24 05:05PM
May-15-24 08:18AM
07:01AM
May-14-24 08:57PM
04:05PM
May-08-24 08:00AM
May-07-24 08:00AM
May-06-24 09:14AM
08:00AM
Apr-24-24 04:35PM
Mar-27-24 10:07AM
07:56AM
Mar-26-24 09:54PM
05:33PM Loading…
05:33PM
04:01PM
Mar-19-24 08:00AM
Mar-07-24 08:00AM
Dec-20-23 08:00AM
Dec-13-23 08:00AM
Dec-06-23 08:00AM
Dec-05-23 08:00AM
Nov-30-23 08:00AM
Nov-28-23 08:00AM
Nov-12-23 09:24AM
Nov-07-23 04:01PM
Nov-06-23 04:05PM
Oct-12-23 07:30AM
Oct-10-23 07:30AM
Sep-06-23 08:00AM
Aug-03-23 04:01PM
06:48AM
Aug-02-23 11:31AM
Aug-01-23 04:01PM
Jul-25-23 08:00AM
Jul-07-23 07:09AM
Jun-26-23 08:00AM
May-31-23 08:00AM
May-11-23 04:01PM
May-08-23 04:05PM
May-04-23 08:00AM
Apr-29-23 09:29AM
Mar-31-23 06:36AM
Mar-27-23 07:12AM
Mar-24-23 11:31AM
Mar-23-23 04:05PM
Mar-16-23 08:00AM
Feb-27-23 08:07AM
Feb-23-23 08:00AM
Jan-25-23 07:10AM
Jan-10-23 08:00AM
Dec-29-22 04:05PM
Dec-22-22 08:00AM
Dec-08-22 08:54AM
Dec-01-22 09:55AM
Nov-15-22 09:55AM
Nov-11-22 08:38AM
Nov-08-22 08:00AM
Nov-04-22 11:15AM
09:08AM
Nov-03-22 04:01PM
Oct-27-22 08:00AM
Sep-23-22 09:15AM
Sep-21-22 10:14AM
Sep-12-22 10:08AM
Aug-18-22 06:39AM
Aug-09-22 07:25PM
04:05PM
Aug-03-22 08:00AM
Aug-02-22 08:00AM
Jun-04-22 08:12AM
Jun-01-22 04:05PM
May-04-22 04:01PM
Apr-08-22 08:00AM
Mar-01-22 06:00AM
Feb-07-22 05:38PM
Jan-10-22 04:05PM
Dec-21-21 09:00AM
Dec-11-21 06:34AM
Nov-15-21 05:09PM
Oct-04-21 10:56AM
Sep-29-21 08:03AM
Sep-12-21 08:49AM
Aug-13-21 05:54PM
BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCBRINN SYLVIADirectorDec 26 '23Buy2.334,0009,32015,125Dec 26 07:43 PM
SHORT JAY M PHDChief Executive OfficerDec 20 '23Buy2.1450,000106,9101,439,283Dec 20 06:27 PM
STEINMAN LAWRENCEDirectorDec 19 '23Buy2.0520,00041,04838,459Dec 19 08:24 PM
Vasquez ChristianSee RemarksDec 19 '23Buy2.047,49515,262115,659Dec 19 04:33 PM